Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
CRNX
FDA Accepts NDA for Paltusotine
| 2024-12-09 |
PHARMACEUTICAL
Crinetics Pharmaceuticals Announces $400M Public Offering
| 2024-10-10 |
PHARMACEUTICAL
